Stretch mark treatment with botulinum toxic

Details for Australian Patent Application No. 2005282967 (hide)

Owner Allergan, Inc.

Inventors First, Eric R.

Agent Davies Collison Cave

Pub. Number AU-A-2005282967

PCT Pub. Number WO2006/028724

Priority 10/934,812 03.09.04 US

Filing date 24 August 2005

Wipo publication date 16 March 2006

International Classifications

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61P 17/02 (2006.01) Drugs for dermatological disorders

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/028724 Priority application(s): WO2006/028724

28 June 2007 Amendment Made

  The nature of the amendment is: Amend the invention title to read Stretch mark treatment with botulinum toxin

13 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005282970-Gas driven actuation feed tube for combustion powered fastener-driving tool

2005282945-System for the attenuation of water bottom multiples in seismic data recorded by pressure sensors and particle motion sensors